R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial von Chamuleau, M.E.D., Stenner, F., Chitu, D.A., Novak, U., Minnema, M.C., Geerts, P., Stevens, W.B.C., Zenz, T., Imhoff, G.W.V., Wu, K.L., Demandt, A.M.P., Kersten, M.J., Terpstra, W.E., Tick, L.W., Deeren, D., Neste, E.V., Gregor, M., Veelken, H., Boehmer, L.H., Caspar, C.B., Mutsaers, P., Refos, J.M., Sewsaran, R., Fu, L.P., Seefat, R.L., Groot, C.A.U.D., Dirnhofer, S., Brand, M.V., Jong, D. de, Nijland, M., Lugtenburg, P.

Volltext bestellen

Clofarabin Added to Standard Treatment in Adult Patients with Newly Diagnosed ALL: First Results of the Randomized Phase III HOVON-100 Study von Rijneveld, A.W., van der Holt, Bronno, de Weerdt, Okke, Biemond, Bart J., van de Loosdrecht, Arjen, Petersen, Eefke, Bellido, Mar, Schouten, Harry C., van der Velden, Walter J F M, Selleslag, Dominik, Schipperus, Martin R., Halkes, Constantijn J.M., Klein, Saskia, Havelange, Violaine, van Marwijk Kooij, Marinus, Legdeur, Marie-Cecile, Refos, Jeannine, van der Velden, Vincent, Cornelissen, Jan J, Homburg, Crista, de Haas, Valerie, Deeren, Dries, Gaddiseur, Alain, Sinnige, Harm, Breems, Dimitri

Volltext